NervGen Pharma Corp Total Liabilities

Latest as of September 2025: CA$16.02 Million CAD ≈ $11.59 Million USD

NervGen Pharma Corp total liabilities. Based on the latest financial reports, NervGen Pharma Corp (NGEN) has total liabilities worth CA$16.02 Million CAD (≈ $11.59 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check NervGen Pharma Corp liquidity resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of NervGen Pharma Corp (2017–2024)

Total liabilities of NervGen Pharma Corp from 2017 to 2024. This chart illustrates how NervGen Pharma Corp's total liabilities have evolved over time, based on quarterly financial data. Explore how much of NervGen Pharma Corp's assets are long-term investments to see how much of total assets are deployed in long-term investments.

NervGen Pharma Corp Competitors by Total Liabilities

The table below lists competitors of NervGen Pharma Corp ranked by their total liabilities.

Company	Country	Total Liabilities
Sprott Focus Trust NASDAQ:FUND	USA	$1.90 Million
Advancetek Enterprise Co Ltd TW:1442	Taiwan	NT$7.62 Billion
Eimskipafélag Íslands hf IC:EIM	Iceland	Ikr370.17 Million
Iron Horse Acquisitions II Corp. Common Stock NASDAQ:IRHO	USA	$11.43 Million
Shanghai CEO Environmental Protection Technology Co Ltd SHG:688335	China	CN¥310.23 Million
Orizon Valorização de Resíduos S.A SA:ORVR3	Brazil	R$2.69 Billion
JCY International Bhd KLSE:5161	Malaysia	RM133.08 Million
Asia Cement (China) Holdings Corporation F:4OJ	Germany	€2.84 Billion

Liability Composition Analysis (2017–2024)

This chart breaks down NervGen Pharma Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see NervGen Pharma Corp asset portfolio.

Liquidity & Leverage Metrics

NervGen Pharma Corp Total Liabilities Ratios Explained

NervGen Pharma Corp total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.79	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-5.45	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.22	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how NervGen Pharma Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for NervGen Pharma Corp (2017–2024)

The table below shows the annual total liabilities of NervGen Pharma Corp from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	CA$16.91 Million ≈ $12.23 Million	+10.92%
2023-12-31	CA$15.25 Million ≈ $11.03 Million	+46.39%
2022-12-31	CA$10.41 Million ≈ $7.53 Million	+865.99%
2021-12-31	CA$1.08 Million ≈ $779.87K	+42.78%
2020-12-31	CA$755.07K ≈ $546.21K	-18.28%
2019-12-31	CA$923.95K ≈ $668.37K	+58.45%
2018-12-31	CA$583.11K ≈ $421.81K	+513.40%
2017-12-31	CA$95.06K ≈ $68.77K	--

About NervGen Pharma Corp

V:NGEN Canada Biotechnology

Market Cap

$295.10 Million

CA$407.94 Million CAD

Market Cap Rank

#14596 Global

#434 in Canada

Share Price

CA$5.15

Change (1 day)

+0.00%

52-Week Range

CA$3.25 - CA$8.08

All Time High

CA$8.08